Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Rahmani, Hosseina; b; * | Blockeel, Hendrikc; d | Bender, Andrease
Affiliations: [a] School of Computer Engineering, Iran University of Science and Technology, Tehran, Iran | [b] Department of Knowledge Engineering, Universiteit Maastricht, Maastricht, The Netherlands | [c] Department of Computer Science, KU Leuven, Leuven, Belgium | [d] Leiden Institute of Advanced Computer Science, Leiden University, CA Leiden, The Netherlands | [e] Unilever Centre for Molecular Science Informatics, Department of Chemistry, University of Cambridge, Cambridge, UK
Correspondence: [*] Corresponding author: Hossein Rahmani, Department of Knowledge Engineering, Universiteit Maastricht, PO Box 616 6200 MD, Maastricht, The Netherlands. E-mail:[email protected]
Abstract: Analyzing different drugs for various purposes is an important issue in the area of computational biology. We categorize the previous computational studies into Individual and Network approaches. While the Individual approach focuses on one specific drug without considering its relationship with other drugs, the Network approach considers also the drugs relationships. In this paper, we apply a Network approach, previously proposed for discovering the relationships among diseases, to drug data. We construct a Human Drug Network (HDN) for 200 different drugs based on functional and structural information available in the PPI network. For evaluating our proposed HDN, first, we analyzed the literature to prove that the proposed HDN is biologically meaningful. Second, we used the HDN to augment the initial prior knowledge of different drugs. As an example of prior knowledge, we considered the initial seed proteins (a set of proteins which are previously known to be drug targets) of each drug. We clustered the HDN nodes using the Markov CLustering Algorithm (MCL) and then, we augmented the seed proteins of each drug based on the cluster it belongs to. In the end, we concluded that our proposed HDN enables us to generate novel hypotheses (in terms of potential drug target proteins) and produce complementary results comparing to existing methods.
Keywords: Human Drug Network, drug-target proteins, protein-protein interaction networks
DOI: 10.3233/IDA-150800
Journal: Intelligent Data Analysis, vol. 20, no. 1, pp. 183-197, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]